Myles A. Brown
Myles A. Brown is an American oncologist who studies connections between hormones, breast cancer, and prostate cancer,[1] particularly focusing on the role of estrogen receptors.[2] He is Emil Frei III Professor of Medicine in the Harvard Medical School,[3] and director of the Center for Functional Cancer Epigenetics in the Dana–Farber Cancer Institute.[1]
Brown was elected to the National Academy of Sciences in 2016,[1] the American Academy of Arts and Sciences in 2017,[4] and the National Academy of Medicine in 2020.[5]
References
[edit]- ^ a b c "Myles A. Brown", Member directory, National Academy of Sciences, retrieved 2021-05-09
- ^ Azar, Beth (July 2018), "Profile of Myles Brown", Proceedings of the National Academy of Sciences, 115 (32): 8054–8056, doi:10.1073/pnas.1810395115, PMC 6094136, PMID 30038006
- ^ Myles Brown, MD, Dana–Farber Cancer Institute, retrieved 2021-05-09
- ^ "Dr. Myles A. Brown", Member directory, American Academy of Arts and Sciences, retrieved 2021-05-09
- ^ National Academy of Medicine Elects 100 New Members, National Academy of Medicine, 19 October 2020, retrieved 2021-05-09
External links
[edit]Myles A. Brown publications indexed by Google Scholar
   | This biographical article related to medicine in the United States is a stub. You can help Wikipedia by expanding it. |